Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus on acromegaly therapeutic outcomes: an update.

Nature reviews. Endocrinology·2025
Same author

Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin.

Frontiers in endocrinology·2024
Same author

IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response.

European journal of endocrinology·2024
Same author

Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis.

ClinicoEconomics and outcomes research : CEOR·2024
Same author

Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly.

Frontiers in endocrinology·2023
Same author

Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database.

International journal of endocrinology·2022

Related Experiment Video

Updated: Jul 15, 2026

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

IGF-I assays: current assay methodologies and their limitations.

David R Clemmons1

  • 1CB# 7170, 8024 Burnett-Womack, Division of Endocrinology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7170, USA. endo@med.unc.edu

Pituitary
|April 13, 2007
PubMed
Summary

Accurate measurement of insulin-like growth factor-I (IGF-I) is crucial for diagnosing growth hormone disorders like GHD and acromegaly. Standardization of IGF-I assays is essential for reliable interpretation of results, especially outside normal ranges.

More Related Videos

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
08:05

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay
09:47

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay

Published on: February 1, 2019

Related Experiment Videos

Last Updated: Jul 15, 2026

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
08:05

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay
09:47

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay

Published on: February 1, 2019

Area of Science:

  • Endocrinology
  • Clinical Chemistry
  • Laboratory Medicine

Background:

  • Insulin-like growth factor-I (IGF-I) measurements are vital for diagnosing and monitoring growth hormone (GH) disorders, including growth hormone deficiency (GHD) and acromegaly.
  • Accurate IGF-I assessment is essential for evaluating GH treatment efficacy in both children and adults.
  • Understanding IGF-I regulation by GH and other factors is key to interpreting assay results correctly.

Purpose of the Study:

  • To highlight the critical role of accurate IGF-I measurement in diagnosing and managing GH-related conditions.
  • To emphasize the technical requirements for reliable laboratory estimation of IGF-I.
  • To address the challenges in standardizing IGF-I assays, particularly for values outside the normal range.

Main Methods:

  • Review of the diagnostic utility of serum IGF-I assays in GHD and acromegaly.
  • Discussion of technical criteria for IGF-I laboratory estimation, including IGF-binding protein (IGFBP) interference.
  • Analysis of commercial assay comparisons and the need for standardization.

Main Results:

  • Serum IGF-I assays are valuable screening tools for GHD and diagnostic aids for acromegaly.
  • Assay performance varies significantly for IGF-I concentrations above or below the normal range.
  • Current commercial assays show variability, hindering cross-laboratory comparisons outside normal ranges.

Conclusions:

  • Accurate IGF-I measurement is indispensable for diagnosing and monitoring GH disorders.
  • Standardization of laboratory techniques and reagents is crucial for reliable IGF-I assessment, especially for abnormal values.
  • Future efforts should focus on developing standardized procedures to reduce variability in IGF-I measurements across laboratories.